About 400 reports

  • Growth in Neurology Devices Market driven by Greater Acceptance of Neurostimulation Devices
  • Canada Neurology Devices Market: By Type, By Value, 2017-2022 (USD Million)

RELATED REPORTS: ##.

  • Neurology
  • World
  • Boston Scientific Corporation
  • Integra LifeSciences Holdings Corporation
  • Jude Medical, Inc.

For instance, as per Neurological Surgeons Society of India (NSSI), there is only ## neuro surgeon for ##. ## million population in India, however, ideal ratio should be one surgeon for ##. ## million to increase in future in Australia.

  • Neurology
  • AngioDynamics, Inc.
  • B. Braun Medical
  • Becton, Dickinson and Company, Ltd
  • Boston Scientific Corporation

A relatively less percentage of diagnosed people undergo surgery for the cure of gastrointestinal problems in the US.

  • Neurology
  • United States
  • World
  • Forecast
  • Olympus Corporation

We are one of the nation' s Top ## health systems.

  • Managed Care
  • Neurology
  • United States
  • Supply
  • GlobalData's company

You can easily book an appointment with one online.

  • Neurology
  • C.R. Bard, Inc.
  • Cook Medical, Inc.
  • Endologix, Inc.
  • Medtronic, Inc.

One St.

  • Managed Care
  • Neurology
  • World
  • Market Size
  • Boston Scientific Corporation

(USA) ##.

  • Hepatitis
  • Neurological Disorder
  • Neurology
  • Pharmaceutical
  • Market Shares

One of the recent developments of the industry is Ovation Prime, a Triivascular Product.

  • Neurology
  • Endologix, Inc.
  • Medtronic, Inc.
  • Nellix, Inc.
  • TriVascular, Inc.

Neuromodulation includes implantable neurostimulation and targeted drug delivery systems for the management of chronic pain, common movement disorders, spasticity, and urologic and gastrointestinal disorders.

  • Neurology
  • World
  • Medtronic, Inc.
  • Penumbra
  • Stryker Corporation

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

The prominent features of this report are - ##.

  • Neurology
  • World
  • Bayer AG
  • GlaxoSmithKline plc
  • Tonix Pharmaceuticals Holding Corp.
  • Number of Deals by Therapy Area, August 2018
  • Deal Value (US$ m) No. of Deals

Besides, one debt offering worth USD##. ##m was recorded in August 2018.

  • Neurology
  • Pharmaceutical
  • World
  • Company
  • Deals & Alliance
  • Central Nervous System
  • Research Contact: info@globaldata.com

Besides, one PE deal worth USD##m was recorded in Q## 2017.

  • Neurology
  • Pharmaceutical
  • World
  • Company
  • Deals & Alliance
  • Central Nervous System

Each unit consists of one share of common stock and a warrant to purchase one share.

  • Neurology
  • Pharmaceutical
  • World
  • Company
  • Deals & Alliance

Besides, one VC deal worth USD##. ##m was reported in Q## 2016.

  • Endocrine Disease
  • Neurology
  • World
  • Company
  • Deals & Alliance

Trials conducted by companies in Phase III, Phase II and Phase I stand at ##, ## and ## respectively.

  • Digestive System Disorder
  • Neurology
  • Therapy
  • World
  • Product Initiative
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Managed Care
  • Australia
  • United States
  • Company Financials
  • Fresenius Group
  • Clinical Trial profile. 303 Trial Title
  • Target

Abdominal Pain Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Abdominal Pain Global Clinical Trials Review, H2, 2018" provides an overview of Abdominal Pain clinical trials scenario.This report provides top line data relating to the clinical trials on Abdominal...

  • Clinical Trial
  • Managed Care
  • Neurology
  • Pharmaceutical
  • World
  • Genentech Inc, Deals By Therapy Area, 2012 to YTD 2018

This study will have an initial focus on gastrointestinal malignancies, including pancreatic and gastric cancers.

  • Immunology
  • Neurology
  • Pharmaceutical
  • Therapy
  • Genentech, Inc.
  • Clinical Trial profile. 137 Trial Title
  • Clinical Trial profile. 105 Trial Title

A Randomized Double Blind Placebo-controlled Study Efficacy of Actiphen on Gastrointestinal Tract Function in Otherwise Healthy Adults.

  • Chronic Pain
  • Managed Care
  • Neurology
  • Pharmaceutical
  • World
  • UCB SA, Deals By Therapy Area, 2012 to YTD 2018

One such project, led by Dr.

  • Autoimmune Disease
  • Managed Care
  • Neurology
  • United States
  • UCB S.A.
  • TARGETS AND PARTNERS
  • Montreal

Paladin Labs Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Paladin Labs Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A),...

  • Neurology
  • Pharmaceutical
  • Canada
  • M&A
  • Paladin Labs Inc.

GLASSIA [Alpha ##-Proteinase Inhibitor (Human)] is a liquid, ready-to-use treatment for alpha-## antitrypsin deficiency (AATD).

  • Cardiology
  • Healthcare
  • Neurology
  • Pharmaceutical
  • Baxter International Inc.
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Clinic
  • Managed Care
  • Medical Education
  • United States
  • GlobalData's company
  • Clinical Trial profile. 275 Trial Title
  • Clinical Trial profile. 603 Trial Title

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Managed Care
  • Neurology
  • Pharmaceutical
  • World

TARGET ##: KIRIN AGRIBIO CO., LTD.

  • Cancer
  • Neurology
  • Japan
  • M&A
  • Kirin Group
  • TARGETS AND PARTNERS
  • ADVISOR INFORMATION

Paladin Labs Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Paladin Labs Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A),...

  • Neurology
  • Pharmaceutical
  • Canada
  • M&A
  • Paladin Labs Inc.

GLASSIA [Alpha ##-Proteinase Inhibitor (Human)] is a liquid, ready-to-use treatment for alpha-## antitrypsin deficiency (AATD).

  • Cardiology
  • Healthcare
  • Neurology
  • Pharmaceutical
  • Baxter International Inc.

TARGET ##: KIRIN AGRIBIO CO., LTD.

  • Cancer
  • Neurology
  • Japan
  • M&A
  • Kirin Group
  • Stock exchange
  • Stock exchange

Company type Partner ##: enGene, Inc.

  • Cardiology
  • Managed Care
  • Neurology
  • United States
  • Takeda Pharmaceutical Company Limited